Banco Bilbao Vizcaya Argentaria, S.A. Paratek Pharmaceuticals, Inc. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

  • $8.53 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$4.19 - $6.69 $439,950 - $702,450
-105,000 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$2.97 - $5.22 $89,100 - $156,600
30,000 Added 40.0%
105,000 $548,000
Q4 2019

Feb 13, 2020
BUY
$2.93 - $4.5 $219,750 - $337,500
75,000 New
75,000 $302,000

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email